Telephone counseling for all hospital staff members in the regions of Lombardy, Emilia Romagna, Veneto, Piedmont
Rome, Italy, (March 26, 2020) – Today, HAL Allergy S.r.l. announced the start of its ‘Prima Linea’ initiative offering telephone counseling for the highly committed hospital staff, who are engaged in the daily fight with the coronavirus in the most affected regions of Italy.
All health and non-health workers, in the hospitals in Italy are working relentlessly with great courage to cope with the increasing number of CoVid-19 patients and its consequences. The commitment of every involved staff member facing tremendous situations every day has led HAL Allergy S.r.l. and Avalon Counseling to set-up this initiative in order to support all of them.
The new service provider ‘Prima Linea’ gives doctors, nurses as well as cooks and other employees working in the hospitals the opportunity to talk confidentially about the exhausting shifts and emotionally devastating situations. Each conversation, free of charge, will be managed by a counseling expert in completely confidential setting as required by the code of ethics and the legislation on the processing of personal data.
Sabrina de Federicis, Country Manager of HAL Allergy S.r.l., states, “I think of the testimony of a young man in his early twenties, who is a cook in one of these hospitals and who, despite the declared anxiety, carries out his work with commitment. Of the nurses or doctors who sleep exhausted on the desks or who manage the sick and their families and the loneliness of everyone.”
The new hotline working from 17 to 20 pm every day, was activated on March 23rd for approximately one month and is a cooperation of HAL Allergy and Avalon Counseling.
We as HAL Allergy, sincerely thank all hospital staff members, who help to cope with the consequences of this pandemic, in Italy and all over the world.
About HAL Allergy
HAL Allergy Group is active in the field of biopharmaceuticals and is located at the Bio Science Park in Leiden, The Netherlands. Our core business is the development and manufacturing of therapies and diagnostics for allergic diseases. With offices in major European countries, HAL Allergy is one of the European top players in the allergy immunotherapy business. Established in 1959 HAL Allergy has long experience in developing, producing and selling allergy therapies with an immuno-modulatory effect causing a reduction in symptoms and long-term disease suppression. The allergy therapies are used against common allergies such as hay fever, house dust mites allergy and allergic reactions towards wasp or bee stings. The main shareholder of HAL Allergy Group is Droege Group AG, based in Düsseldorf, Germany.
More information is available on: www.hal-allergy.com
About Droege Group
Droege Group (founded in 1988) is an independent advisory and investment company under full family ownership. The company acts as a specialist for tailor-made transformation programs aiming to enhance corporate value. Droege Group combines its corporate family-run structure and capital strength into a family-equity business model. The group carries out direct investments with its own equity in corporate spin-offs and medium-sized companies in «special situations». With the guiding principle «execution -following the rules of art», the group is a pioneer in execution-oriented corporate development. Droege Group follows a focused investment strategy based on current megatrends (knowledge, connectivity, prevention, demography, specialization, future work, shopping 4.0). Enthusiasm for quality, innovation and speed determines the company’s actions. In recent years Droege Group has successfully positioned itself in domestic and international markets and operates in 30 countries. More information: www.droege-group.com
Contact HAL Allergy
HAL Allergy B.V.
Monique Lutgens – Manager Corporate Communications
Tel. + 31 (0)88 1959010